Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-CIN HF
2011-003611-37Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate and sodium chloride in contrast-induced nephropathy (CIN) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Started Mar 2012; status: active.
02
Drugs
sodium bicarbonatesodium chloride
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2011-003611-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003611-37.